Author:
Saw Constance L. L.,Chew Lita S. J.,Cai Xiaofeng G.
Reference110 articles.
1. Andjelkovic T, Bankovic J, Stojsic J, Milinkovic V, Podolski-Renic A, Ruzdijic S et al (2011) Coalterations of p53 and PTEN tumor suppressor genes in non-small cell lung carcinoma patients. Transl Res 157:19–28
2. Arnold AM, Browman GP, Levine MN, D’Souza T, Johnstone B, Skingley P et al (1992) The effect of the synthetic retinoid etretinate on sputum cytology: results from a randomised trial. Br J Cancer 65:737–743
3. AstraZeneca Pharmaceuticals LP (2005) Iressa® (gefitinib) tablets [package insert]. Wilmington
4. Azzoli CG, Baker S Jr, Temin S, Pao W, Aliff T, Brahmer J et al (2009) American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer. J Clin Oncol 27:6251–6266
5. Batchelor WB, Heathcote J, Wanless IR (1995) Chaparral-induced hepatic injury. Am J Gastroenterol 90:831–833